Researcher Profile

Keywords Cloud

KRIBB Co-Working

Results 21-40 of 63 (Search time: 0.004 seconds).

No. Year Title Type
43 2020

2020Research Project

질환모델동물을 이용한 Compound I & II의 피부염증 (아토피) 억제 효능 확인 및 기존 시판 약물과의 효능 비교연구책임자 : 김보연 / 사업기간 : 2020.07.24 ~ 2021.01.24
Research Project
42 2020

2020Research Project

UBRs 단백질의 UBR box에 결합하는 ligand의 활성 측정연구책임자 : 성낙균 / 사업기간 : 2020.05.01 ~ 2021.04.30
Research Project
41 2020

2020Research Project

에피프로테옴 기반 발암 및 암전이 치료 신규 원천기술 개발연구책임자 : 김보연 / 사업기간 : 2020.07.01 ~ 2021.06.30
Research Project
40 2020

2020Research Project

혁신 항암기작 기반 항암물질 개발 기술 구축 = Discovery of First-In-Class Anticancer Agents through Innovative Cancer Target Strategy연구책임자 : 차현주 / 사업기간 : 2020.01.01 ~ 2020.12.31
Research Project
39 2019

2019Article

Enhanced anticancer effects of a methylation inhibitor by inhibiting a novel DNMT1 target, CEP 131, in cervical cancerBMB Reports, vol. 52, no. 5, pp. 342-347Dong Hyun Kim; Hye-Min Kim; P T T Huong; Ho Jin Han; Joonsung HwangHyunjoo ChaKyung Ho LeeIn Ja Ryoo; K E Kim; Y H Huh, et al.
Article
38 2019

2019Article

Cep131 overexpression promotes centrosome amplification and colon cancer progression by regulating Plk4 stabilityCell Death & Disease, vol. 10, no. 8, pp. 570-570Dong Hyun Kim; Jong Seog Ahn; Ho Jin Han; Hye-Min Kim; Joonsung HwangKyung Ho LeeHyunjoo ChaIn Ja RyooJae-Hyuk JangSung-Kyun Ko, et al.
Article
37 2019

2019Article

Mechanism of the natural product moracin-O derived MO-460 and its targeting protein hnRNPA2B1 on HIF-1α inhibitionExperimental and Molecular Medicine, vol. 51, no. 2, pp. 10-10Nak Kyun Soung; Hye-Min Kim; Y Asami; Dong Hyun Kim; Yangrae Cho; R Naik; Y Jang; K Jang; H J Han; S R Ganipisetti, et al.
Article
36 2019

2019Research Project

혁신 항암기작 기반 항암물질 개발 기술 구축 = Discovery of First-In-Class Anticancer Agents through Innovative Cancer Target Strategy연구책임자 : 김보연 / 사업기간 : 2019.01.01 ~ 2019.12.31
Research Project
35 2019

2019Research Project

정신 질환 분석을 위한 휴대용 ICT 플랫폼 개발 및 임상 적용을 위한 선행 연구 = Development of a Portable ICT Platform for the Analysis of Mental Illness and Prior Research for Clinical Applications연구책임자 : 권오석 / 사업기간 : 2019.11.01 ~ 2020.08.31
Research Project
34 2019

2019Research Project

에피프로테옴 기반 발암 및 암전이 치료 신규 원천기술 개발연구책임자 : 김보연 / 사업기간 : 2019.07.01 ~ 2020.06.30
Research Project
33 2019

2019Research Project

피부질환 진단기술과 신약개발 고도화연구책임자 : 정흥채 / 사업기간 : 2019.10.16 ~ 2020.03.31
Research Project
32 2018

2018Report

항암 표적 단백질 및 항암 선도물질 발굴 = Discovery of anticancer target protein and anticancer lead compound연구책임자 : 안종석 / 주관부처 : 미래창조과학부안종석김보연이상구홍영수장재혁조성찬성낙균차현주이경호고성균, et al.
Report
31 2018

2018Patent

아실하이드라존 유도체를 포함하는 항염증 조성물KR10-2018-0011046 (2018.01.30) / 10-1839391 (2018.03.12)안종석이희구김보연장재혁성낙균고성균; 안미자; 차현주황준성류인자, et al.
Patent
30 2018

2018Article

The endoplasmic reticulum-residing chaperone BiP is short-lived and metabolized through N-terminal arginylationScience Signaling, vol. 11, no. 511, pp. eaan0630-eaan0630S M Shim; H R Choi; K W Sung; Y J Lee; S T Kim; D Kim; S R Mun; Joonsung HwangHyunjoo Cha; A Ciechanover, et al.
Article
29 2018

2018Article

A novel tubulin inhibitor STK899704 induces tumor regression in DMBA/TPA induced skin carcinogenesis modelExperimental Dermatology, vol. 27, no. 3, pp. 285-288Joonsung HwangNak Kyun Soung; Ho Jin Han; Yongjun Lee; Tae Woong Choi; Jiyun Mun; Hyunjoo ChaKyung Ho Lee; H J Kim; Hee Gu Lee, et al.
Article
28 2018

2018Article

N-terminal arginylation generates a bimodal degron that modulates autophagic proteolysisProceedings of National Academy of Sciences of United States of America, vol. 115, no. 12, pp. e2716-e2724Y D Yoo; S R Mun; C H Ji; K W Sung; K Y Kang; A J Heo; S H Lee; J Y An; Joonsung Hwang; X Q Xie, et al.
Article
27 2018

2018Article

Regulation of autophagic proteolysis by the N-recognin SQSTM1/p62 of the N-end rule pathwayAutophagy, vol. 14, no. 2, pp. 359-361Hyunjoo Cha; Su Hyun Lee; Jung Gi Kim; K W Sung; Joonsung Hwang; S M Shim; S Ganipisetti; T McGuire; I Mook-Jung; A Ciechanover, et al.
Article
26 2018

2018Article

The novel small molecule STK899704 promotes senescence of the human A549 NSCLC cells by inducing DNA damage responses and cell cycle arrestFrontiers in Pharmacology, vol. 9, pp. 163-163C W Park; Y Bak; M J Kim; G Srinivasrao; Joonsung HwangNak Kyun SoungBo Yeon Kim; J H Yu; J T Hong; D Y Yoon
Article
25 2018

2018Article

The N-recognin UBR4 of the N-end rule pathway is required for neurogenesis and homeostasis of cell surface proteinsPLoS One, vol. 13, no. 8, pp. e0202260-e0202260S T Kim; Y J Lee; T Tasaki; Joonsung Hwang; M J Kang; E C Yi; Bo Yeon Kim; Y T Kwon
Article
24 2018

2018Article

The N-recognin UBR4 of the N-end rule pathway is targeted to and required for the biogenesis of the early endosomeJournal of Cell Science, vol. 131, no. 7, pp. 217646-217646S T Kim; Y J Lee; T Tasaki; S R Mun; Joonsung Hwang; M J Kang; S Ganipisetti; E C Yi; Bo Yeon Kim; Y T Kwon
Article
1 2 3 4